Bringing Your Innovations to European Patients

IGES Group with HTA experts at BIO-Europe Spring 2024

The IGES Group is once again taking part in BIO-Europe Spring, one of the largest trade fairs of its kind for the life sciences sector in Europe. The main focus will be on the exchange of information on the European Health Technology Assessment (HTA) procedure, EU-HTA.

BIO-Europe Spring 2024 will take place from 18 to 20 March in Barcelona. Up to 3,700 visitors from more than 2,000 companies from the field of innovative biotechnological medicinal products are expected to attend. The IGES Group is taking part in the event with experts from the life sciences sector. The aim is to enter into dialogue with researchers, companies and associations about international market access and reimbursement strategies for medical innovations.

The focus of this year's discussions is the ongoing HTA harmonisation in Europe, one of the most far-reaching changes in EU pharmaceutical legislation. As stakeholders, companies of IGES Group have been involved in the public consultations on the development of guidelines and guidance documents as part of the EUnetHTA21 activities.

IGES France Pharma Consulting will be on site for the first time as a new company of the IGES Group. Founded at the end of 2023, the company specialises in strategic and health economic consulting services for developers and manufacturers of pharmaceuticals who want to launch products on the market in France and Europe.

The IGES Group as a whole offers a broad range of research and consulting services for global developers and manufacturers of pharmaceuticals, medical devices and digital health applications. The services support almost all phases of the product life cycle management of new developments. They are focussed on the most important European healthcare markets.